Cargando…
Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection
Biomarkers for early diagnosis of hepatocellular carcinoma (HCC) are needed in chronic hepatitis B virus (HBV) infection, a leading cause of HCC. We evaluated whether measurement of serum pentraxin 3 (PTX3) could improve diagnosis of HCC in chronic HBV infection. Data from patients with HBV-related...
Autores principales: | Deng, Huan, Fan, Xiude, Wang, Xiaoyun, Zeng, Lu, Zhang, Kun, Zhang, Xiaoge, Li, Na, Han, Qunying, Lv, Yi, Liu, Zhengwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680106/ https://www.ncbi.nlm.nih.gov/pubmed/33219288 http://dx.doi.org/10.1038/s41598-020-77332-3 |
Ejemplares similares
-
Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Han, Qunying, et al.
Publicado: (2021) -
Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection
por: Li, Fang, et al.
Publicado: (2018) -
Association of LIN28B polymorphisms with chronic hepatitis B virus infection
por: Han, Qunying, et al.
Publicado: (2020) -
Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma
por: Zeng, Lu, et al.
Publicado: (2020) -
Bioinformatics Analysis based on Multiple Databases Identifies Hub Genes Associated with Hepatocellular Carcinoma
por: Zeng, Lu, et al.
Publicado: (2019)